3.65
3.95%
-0.15
Handel nachbörslich:
3.74
0.09
+2.47%
Chromadex Corp Aktie (CDXC) Neueste Nachrichten
Is ChromaDex (CDXC) Stock Outpacing Its Medical Peers This Year? - MSN
ChromaDex to Participate in a Fireside Chat at the Lytham Partners Fall 2024 Investor Conference - The Bakersfield Californian
ChromaDex to Participate in a Fireside Chat at the Lytham Partners Fall 2024 Investor Conference - StockTitan
Is ChromaDex (CDXC) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Two Polish men extradited to NI jailed for drugs offences - Ireland Live
A new experience centre in Bengaluru decodes whisky, gin, and heritage brews of India - Condé Nast Traveller India
Nu Republic launches Cyberstud X2 and Cyberstud X4 Firefly TWS in India - Techlomedia
XLRI JAMSHEDPUR’S PRODZION CLUB HOSTS ITS SECOND PRODUCT SYMPOSIUM: AURORA 2.0 - India Education Diary
Jharkhand News: XLRI Jamshedpur hosts product symposium Aurora - The Jharkhand Story
NI Courts Service awards £85M contract to Canadian IT firm CGI - Belfast Live
Nu Republic Unveils Cyberstud X2 and X4 Firefly Wireless Earbuds - Gadget Bridge
BMS alum Catherine Owen Adams to lead Acadia - BioCentury
Firm appointed on £85m contract to modernise courts system in NI - Belfast Telegraph
'Our NI team is proud to contribute to a program that will impact the present and lay foundation for future innovation' - Belfast News Letter
Check Out Chromadex Corp (CDXC)’s Trade Data Rather Than the Analysts’ Views - SETE News
Northern Ireland courts to receive major IT upgrade - Irish Legal News
Delhi HC upholds Penalty on Custodian for Import of Branded Liquor in Addition to Declared Goods - taxscan.in
ChromaDex appoints new CFO Ozan Pamir - Investing.com
ChromaDex appoints new CFO Ozan Pamir - Investing.com India
County Derry man who operated illegal television streaming service for be sentenced next month - Derry Now
ChromaDex appoints new CFO Ozan Pamir By Investing.com - Investing.com Australia
ChromaDex appoints new CFO Ozan Pamir By Investing.com - Investing.com Canada
ChromaDex Appoints Ozan Pamir As Chief Financial Officer - citybiz
ChromaDex Appoints Ozan Pamir as Chief Financial Officer - StockTitan
Pregabalin: Judge calls for longer drug supply jail terms - BBC.com
'Ludicrous': Derry judge critical of maximum sentence available in wake of case linked to drugs death - Derry Journal
Diageo India opens craft experience home - The Spirits Business
BJP Leader Acquitted in Decade-Old Election Code Case - Town Post
Acer Nitro V 16 AMD Ryzen 7-8845HS NVIDIA GeForce RTX 4060 16GB 1TB SSD - Indiatimes
WINTON GROUP Ltd Invests $597,000 in ChromaDex Co. (NASDAQ:CDXC) - MarketBeat
Insiders own 31% of ChromaDex Corporation (NASDAQ:CDXC) shares but retail investors control 42% of the company - Yahoo Finance
ChromaDex (NASDAQ:CDXC) Stock Price Passes Above Two Hundred Day Moving Average of $3.06 - MarketBeat
Wells Pharma to distribute Niagen IV to new clinics By Investing.com - Investing.com Australia
Wells Pharma to distribute Niagen IV to new clinics - Investing.com India
Wells Pharma to distribute Niagen IV to new clinics - Investing.com
Wells Pharma to distribute Niagen IV to new clinics By Investing.com - Investing.com Canada
ChromaDex Announces Expansion of Pharmaceutical-Grade Niagen® IV and Injection Offerings to Additional Leading Wellness Clinics - Morningstar
ChromaDex Announces Expansion of Pharmaceutical-Grade Niagen® IV and Injection Offerings to Additional Leading Wellness Clinics - StockTitan
ChromaDex Celebrates 25 Years of Innovation and Pioneering NAD+ Research for Healthy Aging Solutions - Business Wire
ChromaDex Celebrates 25 Years of Innovation and Pioneering NAD+ Research for Healthy Aging Solutions - StockTitan
ChromaDex (NASDAQ:CDXC) Shares Pass Above 200 Day Moving Average of $2.99 - MarketBeat
Top investors say Chromadex Corp (CDXC) ticks everything they need - SETE News
Is Chromadex Corp (CDXC) worth investing in despite its undervalued state? - US Post News
ChromaDex Co. (NASDAQ:CDXC) Director Kristin Patrick Sells 23,000 Shares - Defense World
ChromaDex Co. (NASDAQ:CDXC) Director Kristin Patrick Sells 23,000 Shares - MarketBeat
Chromadex director Kristin Patrick sells $82,110 in company stock - Investing.com
ChromaDex to Participate in Renmark’s Virtual Non-Deal Roadshow Series On Thursday, August 29, 2024 - StockTitan
Is Brainsway (BWAY) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
ChromaDex Secures U.S. Patent for the Composition of Matter of Salt Forms of NMNH (Dihydronicotinamide Mononucleotide), a Precursor to NAD+ - Manchestertimes
ChromaDex Secures U.S. Patent for the Composition of Matter of Salt Forms of NMNH (Dihydronicotinamide Mononucleotide), a Precursor to NAD+ - StockTitan
ChromaDex Secures U.S. Patent for the Composition of Matter of Salt Forms of NMNH (Dihydronicotinamide Mononucleotide), a Precursor to NAD+ - Yahoo Finance
Roth Capital Equities Analysts Increase Earnings Estimates for ChromaDex Co. (NASDAQ:CDXC) - MarketBeat
HC Wainwright Reaffirms “Buy” Rating for ChromaDex (NASDAQ:CDXC) - Defense World
Roth Capital Weighs in on ChromaDex Co.’s FY2024 Earnings (NASDAQ:CDXC) - Defense World
ChromaDex Co. (NASDAQ:CDXC) Expected to Post Q2 2025 Earnings of $0.01 Per Share - Defense World
ChromaDex Corporation (NASDAQ:CDXC) Q3 2024 Earnings Call Transcript - Insider Monkey
HC Wainwright Reaffirms "Buy" Rating for ChromaDex (NASDAQ:CDXC) - MarketBeat
Roth Capital Weighs in on ChromaDex Co.'s Q2 2025 Earnings (NASDAQ:CDXC) - MarketBeat
ChromaDex GAAP EPS of $0.00 beats by $0.01, revenue of $22.7M misses by $0.76M - MSN
Earnings call: ChromaDex reports a YoY revenue increase of 12% - Investing.com
Earnings call: ChromaDex reports a YoY revenue increase of 12% - Investing.com India
Earnings call: ChromaDex reports a YoY revenue increase of 12% By Investing.com - Investing.com UK
ChromaDex: Q2 Earnings Snapshot - San Antonio Express-News
ChromaDex: Q2 Earnings Snapshot - Houston Chronicle
ChromaDex Corp (CDXC) Q2 2024 Earnings: EPS Breakeven, Revenue M - GuruFocus.com
ChromaDex: Q2 Earnings Snapshot - San Francisco Chronicle
ChromaDex: Q2 Earnings Snapshot - The Advocate
ChromaDex Corporation Reports Second Quarter 2024 Financial Results - StockTitan
ChromaDex: Q2 Earnings Snapshot - Darien Times
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):